Eusol Biotech Co.,Ltd. (TPEX:6652)
Taiwan · Delayed Price · Currency is TWD 1.960
0.00 (0.00%)
Apr 9, 2026, 2:59 PM CST
Eusol Biotech Market Cap
Eusol Biotech has a market cap or net worth of 268.52 million as of April 20, 2026. Its market cap has decreased by -75.31% in one year.
Market Cap
268.52M
Enterprise Value
-21.03M
Revenue
2.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.96
Market Cap Chart
Since August 29, 2018, Eusol Biotech's market cap has decreased from 5.42B to 268.52M, a decrease of -95.05%. That is a compound annual growth rate of -32.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 268.52M | -66.84% |
| Dec 31, 2025 | 809.67M | -26.13% |
| Dec 31, 2024 | 1.10B | -15.43% |
| Dec 29, 2023 | 1.30B | 16.79% |
| Dec 30, 2022 | 1.11B | -45.27% |
| Dec 30, 2021 | 2.03B | -35.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Level Biotechnology | 1.09B |
| TCI GENE | 967.06M |
| NatureWise Biotech & Medicals | 897.75M |
| BioLASCO Taiwan | 778.60M |
| Neith | 749.77M |
| TaiwanJ Pharmaceuticals | 697.86M |
| SynCore Biotechnology Co.,Ltd | 696.26M |
| Vectorite Biomedical | 643.44M |